BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Cidara Therapeutics Inc. (NASDAQ:CDTX)

1 post

Biotech NewsCidara (CDTX)’s $400 Million Raise: Lifeline or Investor Trap?

  • BioTech Health X
  • August 20, 2025
Cidara Therapeutics Inc. (NASDAQ:CDTX) is a biotechnology company headquartered in San Diego, California, that has built its identity…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Johnson & Johnson (JNJ) Is Trading Near Highs—But Analysts Warn of a Reality Check
  • Analysts Call Boston Scientific (BSX) a “Forever Company” for Investors
  • Cidara (CDTX)’s $400 Million Raise: Lifeline or Investor Trap?
  • Jazz Pharmaceuticals (JAZZ)’s Latest Deal Could Make—or Break—Its Entire Future
  • Will LYTENAVA Make History? Outlook Therapeutics (OTLK)’s Big FDA Moment Approaches
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • August 20, 2025
    Johnson & Johnson (JNJ) Is Trading Near Highs—But Analysts Warn of a Reality Check
    • August 20, 2025
    Analysts Call Boston Scientific (BSX) a “Forever Company” for Investors
    • August 20, 2025
    Cidara (CDTX)’s $400 Million Raise: Lifeline or Investor Trap?
    • August 20, 2025
    Jazz Pharmaceuticals (JAZZ)’s Latest Deal Could Make—or Break—Its Entire Future
    • August 18, 2025
    Will LYTENAVA Make History? Outlook Therapeutics (OTLK)’s Big FDA Moment Approaches
Recent Posts
  • Elicio Therapeutics (ELTX): The Cancer Vaccine Revolution Changing Lives in 2025
    • August 18, 2025
  • Cyclerion Therapeutics (CYCN) Poised for Massive Growth with $1.75M License Deal
    • August 18, 2025
  • Propanc Biopharma (PPCB) Raises $4M: Is This the Hidden Gem of Oncology?
    • August 18, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (323)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top